Sagmeister M, Gessner U, Horisberger B, Gutzwiller F
Medizinische Klinik, Stadtspital Triemli, Zürich.
Schweiz Med Wochenschr. 1998 Mar 7;128(10):356-62.
Mortality from ischemic heart disease (ICD 410-414) is changing. Remarkable decreases have been observed in the age groups from 35-64 years, while overall mortality (all age groups) has remained approximately stable. In Switzerland this has meant a gain of some 4700 life years in the period 1988 to 1993 in the working population (35-64 years). The object of this study was to assess the associated change in indirect costs (productivity losses) due to premature death, using the human capital approach. The indirect costs were CHF 519 million (CHF 7.5 million per 100,000 population) in 1993. This represents approximately half of all indirect costs (and 25% of the total costs generated by the disease). Compared with the year 1988, a decrease in productivity losses due to premature death was observed amounting to CHF 46 million (-11%) in constant Swiss francs. Society benefits from this decrease in indirect costs, a desirable development hardly ever mentioned.
缺血性心脏病（国际疾病分类代码410 - 414）导致的死亡率正在发生变化。在35至64岁年龄组中，死亡率显著下降，而总体死亡率（所有年龄组）基本保持稳定。在瑞士，这意味着在1988年至1993年期间，劳动人口（35至64岁）增加了约4700个生命年。本研究的目的是采用人力资本法评估因过早死亡导致的间接成本（生产力损失）的相关变化。1993年的间接成本为5.19亿瑞士法郎（每10万人口750万瑞士法郎）。这约占所有间接成本的一半（以及该疾病产生的总成本的25%）。与1988年相比，因过早死亡导致的生产力损失以不变瑞士法郎计算减少了4600万瑞士法郎（-11%）。社会从间接成本的这种减少中受益，这一理想的发展却很少被提及。
